1. Home
  2. NWGL vs GTBP Comparison

NWGL vs GTBP Comparison

Compare NWGL & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nature Wood Group Limited

NWGL

Nature Wood Group Limited

N/A

Current Price

$1.16

Market Cap

12.1M

Sector

N/A

ML Signal

N/A

Logo GT Biopharma Inc.

GTBP

GT Biopharma Inc.

HOLD

Current Price

$5.96

Market Cap

12.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWGL
GTBP
Founded
2008
1965
Country
Macau
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.1M
12.4M
IPO Year
2022
2016

Fundamental Metrics

Financial Performance
Metric
NWGL
GTBP
Price
$1.16
$5.96
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 646.1K
110.7K
Earning Date
04-27-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 3.75
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.19
$0.22
52 Week High
$1.98
$11.98

Technical Indicators

Market Signals
Indicator
NWGL
GTBP
Relative Strength Index (RSI) 49.46 54.00
Support Level $1.10 $0.36
Resistance Level $1.48 $11.98
Average True Range (ATR) 0.17 0.51
MACD -0.05 -0.38
Stochastic Oscillator 29.69 8.00

Price Performance

Historical Comparison
NWGL
GTBP

About NWGL Nature Wood Group Limited

CL Workshop Group Ltd, formerly Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: